Amgen, Sanofi’s Cholesterol Drug Spat a Turning Point on Patents
December 27, 2019
Valerie Bauman
Bloomberg Law
Axinn partner Aziz Burgy was quoted in the Bloomberg Law article, "Amgen, Sanofi’s Cholesterol Drug Spat a Turning Point on Patents."
Click here to access the article.